Belyntic
Pre-clinicalAt Belyntic, we are developing new therapies that harness the power of the patients' own immune system.
Founded
2014
Focus
Drug DiscoverySynthetic Biology
About
At Belyntic, we are developing new therapies that harness the power of the patients' own immune system.
Funding History
1Total raised: $2.5M
Seed$2.5MHigh-Tech GründerfondsJun 15, 2022
Company Info
TypePrivate
Founded2014
LocationBerlin, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile